NGS (38) RNGR (57) NOA (59) ACDC (32) ⌘ Pro Terminal →

Core Laboratories Inc. (CLB) Next Earnings Date & Expected ±9.1% Move

$10.40 -0.86% NYSE • Live Quote vs Prior Daily Close (Synced Snapshot)

Core Laboratories Inc. (CLB) carries a Roarable Rating of C+ (Hold) with 68/100 RQD Confidence. The composite score sits in the neutral Hold band (59–69), meaning current holders don’t need to panic-sell while prospective buyers can wait for a move into the 70+ Buy zone.

ROARABLE C+ • HOLD / WATCH Cap $477.2M

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

RQD QUANT TACHOMETERHOLD / WATCH • C+

JEV AI Jury Split (Battleground)

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw C · Rk B

Each axis scored 0–20

12M PRICE TARGET CONE+4.5% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for CLB)Realized 20D OHLCV Swing Band: ±9.1%

NEXT EST. WINDOW: Dec 30, 2026 (~58 DAYS)

Historical OHLCV Volatility ±9.1% Swing Band

±$0.95 Expected Swing

MODEL EARNINGS SETUP GAUGE

CLB Quantitative Pre-Earnings Setup: 68/100

Trailing EPS: $0.65 • YoY Revenue Growth: 0.5%

Model Bullish Setup (68/100)Model Risk Weight (32/100)

Derived deterministically from RQD cash-flow quality, SEC accrual safety, and institutional flow (not a community poll).

LOG YOUR PERSONAL PRE-EARNINGS STANCE (SAVED LOCALLY IN BROWSER):

Recent SEC Reported Revenue, Net Profit & Diluted EPS Cadence

Period	Filed	Revenue	Net Profit	Free Cash Flow	Gross Margin
FY 2025	2025-12-31	$526.5M	$29.7M	$25.8M	20.7%
FY 2024	2024-12-31	$523.8M	$31.4M	$44.5M	19.7%
FY 2023	2023-12-31	$509.8M	$36.7M	$24.8M	20.7%

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher + Options & Swing Structure Desk

Whale Flow & Momentum Playbook: Evaluating CLB & AI Leaders Without Chasing Tops

✓Institutional whale strikes & implied earnings move audit on CLB
✓How disciplined traders manage risk using pre-published trigger & invalidation levels
✓Includes nightly RQD rating-change & forensic signal email alerts on tracked leaders

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

CLB // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -29.01%▼ DESCENDING CHANNEL

2026-10-30O $10.36H $10.79L $10.22C $10.40VOL 880.2K

RES: $12.03SUP: $9.06SMA50: $10.99SMA200: $13.87

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

CLB Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 CLB Butterfly Map → + Track CLB →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

8.7%/yr Implied 5Y Growth

vs. +0.5% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on CLB today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for CLB. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for CLB today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (CLB)

Energy Rank #52 of 211 ⚔️ NGS vs CLB Full Matrix →

1. Head-to-Head Energy Peer Comparison (CLB vs. NGS, RNGR, NOA, ACDC)

Industry: Oilfield Services/Equipment (20 Tracked Issuers)

Across 211 tracked Energy securities in the Roarable RQD universe, Core Laboratories Inc. (CLB) ranks #52 by composite RQD confidence (68/100, grade C+) and #154 by equity capitalization ($477.2M). Within this direct 5-issuer industry benchmark cohort, CLB leads on earnings valuation at 16.1x trailing P/E, while CLB leads on capital efficiency and profitability with 12.6% ROIC and 20.7% gross margin. CLB currently leads its immediate peer cohort in composite quantitative strength at 68/100 (C+).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
CLB ACTIVE Core Laboratories Inc.	C+	68/100	16.1x	20.7%	12.6%	-0.86%	$477.2M	Benchmark Subject
NGS Natural Gas Services Group Inc.	D-	38/100	21.3x	—	10.7%	+0.15%	$424.1M	/ngs-vs-clb →
RNGR Ranger Energy Services Inc. (Class A)	D+	57/100	29.4x	—	4.2%	-0.65%	$361.3M	/rngr-vs-clb →
NOA North American Construction Group Ltd. (no par)	C-	59/100	—	—	—	-0.95%	$347.5M	/noa-vs-clb →
ACDC ProFrac Holding Corp. (Class A)	E	32/100	—	—	-11.4%	-2.81%	$883.3M	/acdc-vs-clb →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001958086

In its most recent audited fiscal period (FY2025, filed 2025-12-31), Core Laboratories Inc. (CLB) reported GAAP revenue of $526.5M (+0.5% vs. FY2024 revenue of $523.8M , and +3.3% cumulative change since FY2023) , GAAP net income of $29.7M, operating cash flow of $37.0M, and free cash flow of $25.8M (-42.0% YoY). On the balance sheet, CLB closed FY2025 with $584.0M in total assets against $110.3M in total debt (Altman Z-Score: N/A, Piotroski F-Score: 6/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2025-12-31	$526.5M	$29.7M	$37.0M	$25.8M	$584.0M	$110.3M
FY2024 (FY)	2024-12-31	$523.8M	$31.4M	$56.4M	$44.5M	$585.1M	$126.1M
FY2023 (FY)	2023-12-31	$509.8M	$36.7M	$24.8M	$24.8M	—	—

3. CLB Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is CLB stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-01, Core Laboratories Inc. (NYSE: CLB) is rated C+ (Hold / HOLD) by Roarable's 5-pillar RQD engine with a composite confidence score of 68/100 at a spot price of $10.40 (-0.86% 1D, market cap $477.2M). Pillar breakdown: Fundamental Cash Engine 13/20, Institutional 13F & Options Flow 9/20, Executive Insider Alignment 13/20, FRED Macro Regime Fit 17/20, and SEC Balance-Sheet Forensics 16/20. Across 211 tracked Energy issuers, CLB ranks #52 in composite RQD confidence.

How does CLB compare to NGS and RNGR in the Energy sector?

Within the Energy sector (Oilfield Services/Equipment), CLB carries a Roarable C+ (68/100 RQD), trailing P/E of 16.1x, gross margin of 20.7%, and ROIC of 12.6%. By comparison, NGS (Natural Gas Services Group Inc.) holds a D- grade (38/100 RQD, P/E 21.3x, ROIC 10.7%, cap $424.1M) and RNGR (Ranger Energy Services Inc. (Class A)) posts a D+ grade (57/100 RQD, P/E 29.4x, ROIC 4.2%, cap $361.3M). Among the 5-stock peer group, CLB leads on earnings multiple (16.1x) while CLB leads on capital efficiency (12.6% ROIC).

What are the biggest fundamental strengths and SEC risk factors for CLB?

Per CLB's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001958086), Core Laboratories Inc. generated $526.5M in revenue (+0.5% YoY), $29.7M in net income, and $25.8M in free cash flow against $584.0M in total assets and $110.3M in total debt. Key quantitative strengths: Company leadership has skin in the game with net positive insider conviction.. Primary risk factors monitored: Broader market pullbacks can still drag down strong stocks in the short run.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is CLB trading relative to its 50-day, 200-day, and 52-week technical levels?

CLB last traded at $10.40 (-0.86% on volume of 1,036,406 shares), positioning the stock -5.37% below its 50-day simple moving average ($10.99) and -25.02% below its 200-day simple moving average ($13.87). Across its 52-week range of $9.13 to $20.36, CLB sits at the 11.3% percentile with a 14-day RSI of 54.9 (NEUTRAL RANGE) and an implied next-earnings move of ±9.1% ($9.45 to $11.35).